Literature DB >> 8621564

Poly(ADP-ribosyl)ation of histone H1 correlates with internucleosomal DNA fragmentation during apoptosis.

Y S Yoon1, J W Kim, K W Kang, Y S Kim, K H Choi, C O Joe.   

Abstract

The biochemical role of poly(ADP-ribosyl)ation on internucleosomal DNA fragmentation associated with apoptosis was investigated in HL 60 human premyelocytic leukemia cells. It was found that UV light and chemotherapeutic drugs including adriamycin, mitomycin C, and cisplatin increased poly(ADP-ribosyl)ation of nuclear proteins, particularly histone H1. A poly(ADP-ribose) polymerase inhibitor, 3-aminobenzamide, prevented both internucleosomal DNA fragmentation and histone H1 poly(ADP-ribosyl)ation in cells treated with the apoptosis inducers. When nuclear chromatin was made accessible to the exogenous nuclease in a permeabilized cell system, chromatin of UV-treated cells was more susceptible to micrococcal nuclease than the chromatin of control cells. Suppression of histone H1 poly(ADP-ribosyl)ation by 3-aminobenzamide reduced the micrococcal nuclease digestibility of internucleosomal chromatin in UV-treated cells. These results suggest that the poly(ADP-ribosyl)ation of histone H1 correlates with the internucleosomal DNA fragmentation during apoptosis mediated by DNA damaging agents. This suggestion is supported by the finding that xeroderma pigmentosum cells which are defective in introducing incision at the site of DNA damage, failed to induce DNA fragmentation as well as histone H1 poly(ADP-ribosyl)ation after UV irradiation. We propose that poly(ADP-ribosyl)ation of histone H1 protein in the early stage of apoptosis facilitates internucleosomal DNA fragmentation by increasing the susceptibility of chromatin to cellular endonuclease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621564     DOI: 10.1074/jbc.271.15.9129

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Poly(ADP-ribosylation) and apoptosis.

Authors:  A I Scovassi; G G Poirier
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

2.  Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication.

Authors:  C M Simbulan-Rosenthal; D S Rosenthal; S Iyer; H Boulares; M E Smulson
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

3.  Transformed cells require continuous activity of RNA polymerase II to resist oncogene-induced apoptosis.

Authors:  C Koumenis; A Giaccia
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

4.  Response of Dictyostelium discoideum to UV-C and involvement of poly (ADP-ribose) polymerase.

Authors:  H Mir; T Alex; J Rajawat; A Kadam; R Begum
Journal:  Cell Prolif       Date:  2015-04-08       Impact factor: 6.831

5.  Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence.

Authors:  C M Simbulan-Rosenthal; D S Rosenthal; R B Luo; R Samara; M Jung; A Dritschilo; A Spoonde; M E Smulson
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

Review 6.  Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?

Authors:  Paul O Hassa; Sandra S Haenni; Michael Elser; Michael O Hottiger
Journal:  Microbiol Mol Biol Rev       Date:  2006-09       Impact factor: 11.056

7.  Nucleotides induce higher order chromatin degradation.

Authors:  Monika Banaszewska; Gregory W Konat
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

8.  Elevation of apoptotic potential by anoxia hyperoxia shift in NIH3T3 cells.

Authors:  Y C Chen; S H Tsai; S Y Lin-Shiau; J K Lin
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

9.  PARP-1 inhibits glycolysis in ischemic kidneys.

Authors:  Kishor Devalaraja-Narashimha; Babu J Padanilam
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

10.  Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids.

Authors:  W Günther; E Pawlak; R Damasceno; H Arnold; A J Terzis
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.